IRWD Q2 2018 Earnings — Ironwood Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

IRWDIronwood Pharmaceuticals, Inc.

$603M

Q2 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$81M+24.6% YoY

Gross Profit

$77M95.0% margin

Operating Income

-$40M-49.2% margin

Net Income

-$49M-60.9% margin

EPS (Diluted)

$-0.32

QoQ Revenue Growth

+17.3%

Cash Flow

Operating Cash Flow

-$23M

Free Cash Flow

-$24M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$618M

Total Liabilities

$662M

Stockholders' Equity

-$44M

Cash & Equivalents

$145M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$81M	$65M	+24.6%
Gross Profit	$77M	$62M	+25.1%
Operating Income	-$40M	-$41M	+2.7%
Net Income	-$49M	-$44M	-11.7%

Revenue Segments

Active Pharmaceutical Ingredient

$9M89%

Product

$1M11%

Geographic Segments

J

$9M100%